Florian Janisch

Presentation(s):

• MP14-09: Differential risk stratification of Memorial Sloan Kettering Cancer Center (MSKCC) and the International Metastatic RCC Database Consortium (IMDC) prognostic score in patients with metastatic renal cell carcinoma (mRCC) treated with tyrosine-kinase inhibitors (TKI).

  Friday, May 15, 2020
  7:00 AM – 9:00 AM